ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

74
Analysis
Health Care • Australia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
•12 Sep 2023 06:30

Australia: S&P/ASX, REMX, GDXJ, MVA, MVW & Other Index Flows on Friday

There are a bunch of rebalances that will be implemented in Australia on Friday. Nearly 100 stocks will have over A$5m or more than 3x ADV to...

Logo
698 Views
Share
bullish•Lasertec Corp
•10 Sep 2023 06:30

Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, KOSDAQ150, Yuanta ETFs, MVA, MVW, SMH

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
784 Views
Share
bullish•Boss Energy
•06 Sep 2023 05:00

Mergers, Acquisitions and Potential S&P/ASX Index Ad Hoc Inclusions

There are 5 companies that are members of the S&P/ASX indices and could be delisted prior to the next rebalance in December. That could mean ad hoc...

Logo
818 Views
Share
•04 Sep 2023 05:00

S&P/​​​​ASX Index Rebalance (Sep 2023): Mostly Expected with a Few Surprises

There are 30 changes for the SP/ASX index family in Sep. Most of the changes were expected but there are a few surprises. There is a lot to trade...

Logo
754 Views
Share
•03 Sep 2023 06:11

Quiddity ASX Sep 23 Rebal: 15 Inflow/Outflow Names; Beware of Short Buildup; US$450mn One-Way

The Inclusion/Exclusion events can be expected to take place at the close of Friday 15th September 2023. I would be Bullish Inflow Names and...

Share
x